We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Chemiluminescence Immunoassay (CLIA) Analyzers Market to Surpass USD 7.5 Billion by 2025

By LabMedica International staff writers
Posted on 30 Nov 2021

The global chemiluminescence immunoassay (CLIA) analyzers market is estimated to grow at a CAGR of 6. More...

4% in the forecast period of 2020-2025 to reach USD 7.6 billion by 2025, with the reagents segment anticipated to capture almost three-fourth of the overall CLIA analyzers market and reach USD 5.7 billion by the end of 2025. The COVID-19 pandemic is anticipated to provide further impetus to the global CLIA analyzers market. Several market players and healthcare agencies are investing in developing COVID-19 diagnostic tests based on the CLIA technique.

These are the latest findings of Fact.MR (Rockville, MD, USA), a market research and competitive intelligence provider.

Infectious disease, autoimmune disease, cardiovascular disease, diabetes, obesity, and cancer are among the chronic disorders for which CLIA solutions are commonly used. They are also used for therapeutic medication monitoring by a number of pharmaceutical corporations and research institutes. Rising awareness of early identification of chronic diseases, and increased medication discovery and development activity by pharmaceutical companies are the key growth drivers of the global CLIA analyzers market. Additionally, rising demand for faster and specific diagnosis to support rapid decision-making is boosting the demand for multiplexed and automated CLIA analyzers. Moreover, the leading players in the CLIA analyzers market have invested heavily in designing several CLIA techniques. This is expected to help them find potential growth inhibiting techniques to contain the spread of COVID-19.

Semi-automated analyzers are anticipated to expand at a healthy CAGR of 6.4% during the forecast period, driven by an uptick in the number of market players offering integrated systems and the prevalence of multiplexed analyzers. By application, the endocrine disorders segment promises impressive growth, mainly due to continuous innovations in test offerings and wide production portfolios of key manufacturers. The endocrine disorders segment is projected to capture almost half the share of the global CLIA analyzers market and register a CAGR of 6.9% during the forecast period. By end-use, the clinical laboratories segment is projected to register a relatively higher CAGR of 6.6% due to rising penetration of private laboratories and growing preference among patients for clinical laboratories. Moreover, the expanding base of clinical laboratories and increase in number of test procedures are likely to drive the growth of the clinical laboratories segment.

Geographically, North America is expected to continue dominating the global CLIA analyzers market, owing to burgeoning demand for faster and specific diagnosis to aid decision-making among end-users. North America is expected to capture nearly two-fifth share of the global CLIA analyzers market and register a CAGR of 6.1% during the forecast period. The Asia-Pacific market for CLIA analyzers has lucrative growth prospects due to the gradual adoption of novel products incorporating CLIA technologies, intensifying market competition among the key players and greater accreditations to establish more laboratories. Asia-Pacific is anticipated to capture a quarter of the global CLIA analyzers market.

Related Links:
Fact.MR 


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test analyzes biomarkers in uterine fluid to detect endometrial cancer (Photo courtesy of 123RF)

ELISA-Based Test Uses Gynecologic Fluids to Detect Endometrial Cancer

Every year, 35 million postmenopausal women worldwide experience abnormal uterine bleeding (AUB), the primary trigger for initiating endometrial cancer diagnosis. Around 5% of these women will develop... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.